comparemela.com

Latest Breaking News On - Catherinet doherty - Page 2 : comparemela.com

Quest Diagnostics Incorporated (NYSE:DGX) Receives $144 18 Average Target Price from Analysts

Quest Diagnostics Incorporated (NYSE:DGX) Receives $144 18 Average Target Price from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Quest Diagnostics Incorporated (NYSE:DGX) Receives $144 18 Average Price Target from Brokerages

Quest Diagnostics Incorporated (NYSE:DGX) Receives $144 18 Average Price Target from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Citigroup Increases Quest Diagnostics (NYSE:DGX) Price Target to $145 00

Quest Diagnostics (NYSE:DGX – Free Report) had its target price upped by Citigroup from $135.00 to $145.00 in a report released on Wednesday, Benzinga reports. The firm currently has a neutral rating on the medical research company’s stock. Other research analysts have also recently issued research reports about the stock. SVB Leerink initiated coverage on […]

Yousif Capital Management LLC Reduces Position in Quest Diagnostics Incorporated (NYSE:DGX)

Yousif Capital Management LLC decreased its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 4.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,102 shares of the medical research company’s stock after selling 1,236 shares during the […]

Quest Diagnostics Incorporated (NYSE:DGX) Shares Sold by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC trimmed its holdings in shares of Quest Diagnostics Incorporated (NYSE:DGX – Free Report) by 9.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,822 shares of the medical research company’s stock after selling 189 shares during the quarter. […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.